Ana səhifə

Electronic physician


Yüklə 2.11 Mb.
səhifə6/8
tarix27.06.2016
ölçüsü2.11 Mb.
1   2   3   4   5   6   7   8

Papillary Thyroid Cancer with diffuse lung metastasis
Somayeh khosravi 1, Shirin Hasani Ranjbar 1, Sayeh Alizad Jahani 2
1. M.D., Endocrinology and Metabolism Research Center, Tehran University of Medical Sciences, Tehran, Iran

2. Endocrinology and Metabolism Research Center, Tehran University of Medical Sciences, Tehran, Iran
Sh_hasani@sina.tums.ac.ir
Abstract: Thyroid carcinoma is a rare condition comprising 1% of all malignancies. Thyroid malignancies presenting with dyspnea and milliary metastasis are also rare. To manage and confirm lung metastasis in such cases beside evaluation of tuberculosis and other infections, considering iodine avidity and thyroglubolin levels are critical. In this situation, pulmonary fibrosis may be a severe side-effect and the indication for repeated courses of radioiodine therapy has to be decided thoroughly. Hyroglobulin level and the size of pulmonary nodules could be helpful for differentiating active lung metastasis from fibrosis. Here we report an Eighty years old man suffering from Papillary Thyroid Cancer with Follicular Variant and milliary lung metastasis at presentation.

Bibliographic Information of this article:

[Somayeh khosravi, Shirin Hasani Ranjbar, Sayeh Alizad Jahani. Papillary Thyroid Cancer with diffuse lung metastasis. Electronic Physician, 2012;4(2):555-559. Available at: http://www.ephysician.ir/2012/555-559.pdf ]. (ISSN: 2008-5842). http://www.ephysician.ir


Keywords: Papillary carcinoma; Follicular Variant; Thyroid nodule; Milliary lung metastasis

© 2009-2012 Electronic Physician

1. Introduction

Papillary thyroid carcinoma (PTC) is the most frequent type of thyroid cancer. Recent studies showed that the incidence of PTC is growing ( between 2.7 to 7.7 per 100,000) (1, 2) .Some factors may be responsible for the increased incidence of this tumor. The first is detection of small early lesions by ultrasonography and fine-needle aspiration (FNA). The second is the better recognition of the follicular variant of papillary carcinoma (FVPTC). Other factors include more common exposure to the ionizing radiation and a more iodine rich diet. Of the several histological variants of papillary carcinoma the follicular variant is to be probably most common (accounting for about 10 percent of all PTCs) (3). The overall prognosis for papillary thyroid carcinomas is very good with a 10-year survival rate of 93% (4). Distant metastases which need higher activities of radioiodine are less frequent with 10-20%. Ten percent of patients have metastases beyond the neck at the time of diagnosis. Between such patients 25 percent have skeletal metastases, and 75 percent have pulmonary metastases, but milliary pattern of lung metastasis is very rare in PTC. A specific finding in children is disseminated, milliary lung metastases with intense radioiodine uptake. The 10-year survival rate is 30 to 50 percent. Still higher survival rates have been noted in patients whose pulmonary metastases could be detected by radioiodine imaging (5). Even in advanced cases of childhood thyroid cancer, long-lasting remissions can be achieved. Follicular-variant papillary cancers (FVPTC) are likely to be smaller than common-type papillary cancers, and the risk of regional lymph node metastases may be uncommon (6, 7). One of the differential diagnoses of milliary nodules in lungs is thyroid carcinoma in which, increasing thyroglobulin (Tg) levels and positive radioactive iodine uptake are diagnostic (8). Since the 1940s Radioiodine (131-I) therapy has been used for patients with papillary or follicular thyroid cancer (9). Radioiodine has both scanning and treatment aspects. Patients were treated with 131-I have a five-year survival rate of 60 percent, compared with 30 percent in those whose tumors do not concentrate 131-I (10). Here we report a patient suffering from Papillary Thyroid Cancer with Follicular Variant and milliary lung metastasis at presentation who was treated with radio iodine and discuss the challenging management of such cases.


2. Case Presentation

An 18 year old man presented initially with weight loss (10kg) in two month and a 3 month history of a mass on the right side of his neck, which had recently increased in size. The patient had no past history of neck radiation or a family history of thyroid cancer. The lymph nodes of the lateral compartment of neck were significantly enlarged. Physical examination revealed a palpable firm, fixed mass measuring 3.5×2.5 ×2cm in right lobe. The margins were irregular. The left lobe and the isthmus were soft without any abnormality and two lymph nodes measuring 0.5×0.5 were palpable bilaterally. Chest examination revealed diffuse crackle. Physical examination of other organs was unremarkable. Ultrasonography of thyroid was compatible with an irregular mass in right lobe of thyroid and multiple enlargements of cervical lymph nodes bilaterally.





Figure1. Chest X Ray showed diffuse nodular opacities in both lung fields (snow storm view)

Fine Needle Aspiration Cytology (FNAC) of right thyroid nodule revealed papillary thyroid carcinoma with follicular variant. Hematologic data including Complete Blood Count (CBC), electrolytes, Blood Urea Nitrogen (BUN), creatinine, Erytrocyte Sedemination Rate (ESR), Fasting Blood Sugar (FBS) were within normal limits. Thyroid function tests revealed the following values: Triiodothyronine (T3): 80µg/dl, Thyroxine (T4): 4.4µg/dl, Thyroid stimulating hormone (TSH): 6.4MIU/L, and Thyroglobulin (Tg) :1090 ng/ml. Total thyroidectomy with central node dissection was conducted and then the patient was treated with 150 mic Radioactive Iodine-131. Levothyroxine sodium (150 microgram daily) was prescribed. Ultrasonography in this stage reported that thyroid tissue and cervical lymph nodes were not seen. After 1 month, he presented to clinic with Tonic-clonic seizure and urine incontinency and laboratory data reported the serum calcium level at 5mg/l.

Brain CT scan for rule out of metastasis was done and reported normal; so according to history of neck dissection and biochemical tests, secondary hypoparathyroidism due to thyroidectomy was diagnosed. Patient underwent treatment whit pearl Rocatrol (6/daily) and Calcium Carbonate (3000 mg/daily). He was discharged with normal serum calcium concentration. After two months, productive cough, dyspnea, orthopnea, and paroxysmal nocturnal dyspnea gradually added to first manifestations and then progressive cyanosis of the lips and fingers was appeared. Chest x ray showed infiltrated nodular snow storm viewed (figure 1). In HRCT scan with contrast there was innumerable small parenchymal nodular lesions (Figure 2). However, considering diffuse milliary pattern at both lungs witch mostly suggested milliary tuberculosis; broncoscopy with alveolar lavage was done that was negative for tuberculosis and also no fungal or other micro-organisms were detected.



Figure 2. Spiral HRCT with contrast: innumerable small parenchymal nodular

Echocardiography was unremarkable but mild pericardial effusion was detected and pulmonary artery pressure (PAP) was 20mmHg. In this regard, pulmonary function tests (PFT) was done that reported: FEU: 41%, FEV1/FVC: 83%. Pulmonary embolus was ruled out by pulmonary ventilation/perfusion scan. Retrospectively post radio iodine ablation scan revealed, increasing uptake in both lungs and confirmed iodine avid thyroid tumor metastasis.

Based on consultation with respiratory service radioiodine (I-131) therapy with dosimetry was recommended for him. According to the documentation provided Respiratory distress in the field of Pulmonary metastasis was enhanced against other differential diagnosis such as (pulmonary fibrosis), in this regard radioiodine (I-131) therapy with 170 mic was done. After 3 days increasing uptake in lungs was reported in post ablation scan. On the other hand Tg level was more than 1000ng/ml. The patient was treated with Levothroxine sodium (1/5 daily) and after six months, respiratory symptoms declined and the patient was ready to receive the next dose of radioiodine therapy.
3. Discussions

According to latest edition of American Thyroid Association (ATA), PTC has 15 variants. The follicular variant of papillary carcinoma (FVPTC) is the most frequent type of PTC witch firstly described by Hazard and Crile in 1953 who named this lesion alveolar variant of PTC (11). From time to time, patients present with metastasis in a neck lymph node or with hoarseness of voice caused by involvement of the recurrent laryngeal nerve. Infrequently, FVPTC gives rise to lung metastases in the nonexistence of lymph node involvement (12). Conversely, follicular thyroid cancer showed more distant metastases than papillary thyroid cancer (13, 14).

Follicular carcinoma and follicular adenoma are main differential diagnoses of this tumor. FVPTC may show partially or completely encapsulated (15, 16) in relation to pure papillary thyroid carcinoma, difficulties in pre-operative diagnosis and high ratios of first clinical presentation with distant metastases were the main problems to be conquer (17).

In same case report that Owned to a 10 year-old-boy with pulmonary metastases under taken thyriodectomy and has received two doses of ablative therapy and improved. Thyroglobin levels and his general condition were good after ablative therapy (18). There are case reports of this entity in literature presenting as lung metastasis.

According to American Thyroid Association Guidelines these macronodular pulmonary metastases may be treated with RAI if demonstrated to be iodine avid (19). Complete remission is not common and survival remains poor. To manage and confirm lung metastasis in such cases beside evaluation of tuberculosis and other infections, considering iodine avidity and thyroglubolin levels are critical. In this situation, pulmonary fibrosis may be a severe side-effect and the indication for repeated courses of radioiodine therapy has to be decided thoroughly (20). In follow up thyroglobulin level and the size of pulmonary nodules could be helpful for differentiating active lung metastasis from fibrosis to decide for repeated Radi iodine ablation.
Acknowledgements:

The authors thank the Endocrionology & Metabolism research Institute of Tehran University of Medical Sciences, for their support and contribution to this study.


Corresponding Author:

Dr. Shirin Hasani Ranjbar

Endocrinology and Metabolism Research Center

Shariati Hospital, Tehran, Iran

Tel: +98.2188220037

Fax: +98.2188220052



E-mail: Sh_hasani@sina.tums.ac.ir and shirinhasanir@yahoo.com
References

  1. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006; 295:2164.

  2. Enewold L, Zhu K, Ron E, Marrogi AJ, Stojadinovic A, Peoples GE, Devesa SS. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev. 2009;18(3):784

  3. Tielens ET,Sherman SI,HRUBAN rh,Ladenson PW.Follicular variant of papillary thyroid carcinoma.Aclinicopathologic study .A clinicopathology study .Cancer 1994;73:424.

  4. Mazzaferri EL, Kloos RT. Current approaches to primary therapyfor papillary and follicular thyroid cancer. J Clin Endocrinol Metab 1953;138:33-8.

  5. Casara D, Rubello D, Saladini G, et al. Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables. J Nucl Med 1993; 34:1626.

  6. Tielens ET, Sherman SI, Hruban RH, Ladenson PW. Follicular variant of papillary thyroid carcinoma. A clinicopathologic study. Cancer 1994; 73:424.

  7. Zidan J, Karen D, Stein M, et al. Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survival. Cancer 2003; 97:1181.

  8. Seyfettin Ilgan1, A. Ozgur Karacalioglu1, Yuksel Pabuscu2, G. Kaan Atac2, Nuri Arslan1, Emel Ozturk1,Bengul Gunalp1, M. Ali Ozguven. Iodine-131 treatment and high-resolution CT: results in patients with lung metastases from differentiated thyroid carcinoma .Springer2004; 31 : 825-830

  9. Spitzweg C, Harrington KJ, Pinke LA, et al. Clinical review 132: The sodium iodide symporter and its potential role in cancer therapy. J Clin Endocrinol Metab 2001; 86:3327.

  10. Maxon, HR, Smith, HS. Radioiodine-131 in the diagnosis and treatment of metastatic well-differentiated thyroid cancer. Endocrinol Metab Clin North Am 1990; 19:685

  11. Crile G, Hazard JB. Relationship of the age of the patient to the natural history andprognosis of carcinoma of the thyroid. Ann Surg 1953;138:33–8.

  12. Baloch ZW, LiVolsi VA. Follicular-patterned lesions of the thyroid: the bane of thepathologist. Am J Clin Pathol 2002;117:143–50.

  13. Simpson WJ, Panzarella T, Carruthers JS, et al.Multivariate analysis of survival in differentiated thyroid cancer: the prognostic significance of the age factor. Eur J Cancer Clin Oncol 1988;24:331–7

  14. Samaan NA, Schultz PN, Hickey RC, Goepfert H, Haynie TP, Johnston DA, et al.The results of various modalities of treatment of well differentiated thyroid carcinoma: a retrospective review of 1599 patients. J Clin Endocrinol Metab 1992;75:714-20.

  15. Castro P, Fonseca E, Magalha˜es J, et al. Follicular, papillary, and hybrid carcinomasof the thyroid. Endocr Pathol 2002;13:313–20.

  16. Rosai J, Zampi G, Carcangiu ML. Papillary carcinoma of the thyroid: a discussion ofits several morphologic expressions, with particular emphasis on the follicular variant.Am J Surg Pathol 1983;7:809–17.

  17. Goodell WM, Saboorian MH, Ashfaq R.Fine-needle aspiration diagnosis of the follicular variant of papillary carcinoma. Cancer 1998;84:349-54.

  18. Josephina C.J. Vermeer-Mens, Natascha N.T. Goemaere,Vibeke Kuenen-Boumeester, Sabine M.P.F. de Muinck Keizer-Schrama, Christian M. Zwaan, Annick S. Devos, and Ronald R. de Krijger 2006

  19. Cooper CS,Doherty GM.HaugenBR,KLoosRT,LeeSL,Mandel SJ.Mazzaferri EL, MclverB,Pacini F.Schlumberger M,Sherman SI,Steward DL,Tuttle RM.Revised American Thyroid Association management guidelines for patients with thyroid nodule and differentiated thyroid canser.Thyroid,2009;19(11)1167-214

  20. Reiners C, Demidchik YE, Drozd VM, Biko J. Thyroid cancer in infants and adolescents after Chernobyl. Minerva Endocrinol. 2008 Dec;33(4):381-95.


Original Article
Evidence Based Education System (EBES): Our Achievements and way forward
Suresh Kumar Rathi 1, Sandip Shah 2
1. Department of Community Medicine, SBKS Medical Institute and Research Centre, Sumandeep Vidyapeeth, Vadodara, India

2. Director Research, Sumandeep Vidyapeeth, Vadodara, India
rathisj@yahoo.com

Abstract:

Introduction: Till date Medical Educators used to teach as they have been taught. In India; even today a large number of the doctors working as faculty in Medical Colleges are not really trained to teach. Hence, introducing educators to the Evidence Based Education System (EBES) and implementation of EBES curriculum is need of the hour. EBES is the integration of professional wisdom with the best available empirical evidence in making decisions about how to deliver instructions. Therefore, the purpose of study is to develop and implement EBES Curriculum.

Methods: There are various ways to deliver instructions including Evidence Based Medicine (EBM). EBM is the process of systematically reviewing, appraising and using clinical research findings to aid the delivery of optimum clinical care to patients. Here, in Sumandeep Vidyapeeth (SV), we introduced EBM on January 23, 2007 but decided to implement it in phase manner (Phase –I, II, and III). Year wise curriculum for EBM and assessment techniques (Assignments and Annual Examination) was developed. Library resources were enhanced to enable best searches of current literature. We have also sensitized the educators through inhouse, national and international workshops and also through an International Conference.

Results: Batch of first year MBBS for the year 2010-11 gone through the EBM examination and cleared it. Currently, EBM course is being implemented for 2nd year MBBS batch. Faculty feedback for EBM workshop is as follows: Overall rating by the participants for teaching EBM session by the resource persons was 85% from very good to excellent. Rating for searching evidence session was 56% from very good to excellent. However, rating for critical appraisal of the article session was only 44% from very good to excellent.

Conclusion: Based on our findings we conclude that this system is highly effective for delivering teaching instructions and if we will be able to implement for all four years of MBBS then we will very soon achieve the target of not only health for all but also Millennium Development Goals for our area.


Bibliographic Information of this article:

[Suresh Kumar Rathi, Sandip Shah. Evidence Based Education System (EBES): Our Achievements and way forward. Electronic Physician, 2012;4(2):560-564. Available at: http://www.ephysician.ir/2012/560-564.pdf ]. (ISSN: 2008-5842). http://www.ephysician.ir


Keywords: Evidence Based Medicine; Evidence Based Practice; Teaching Methods; India

© 2009-2012 Electronic Physician

1. Introduction

Nintheenth century was the century of Prevention and Public Health (Water and sanitation and hygiene), 20th century was of Antibiotics /chemotherapy /drug development (early diagnosis and prompt treatment) and 21st century is of innovation, knowledge and knowledge translation into practice through sufficient evidences. Over the past few years there has been a paradigm shift in the way education system has evolved in many affluent countries (1, 2). There has been a shift in terms of both teaching system and curriculum (3). Till date Medical Educators used to teach as they have been taught (4). No formal training programs for educators existed. The teaching crisis we face today is the direct result of the divorce between theory and practice. As Singh et al highlighted the role of Medical Education Unit (MEU) in faculty development4 and also in India every medical college is supposed to have Medical Education Unit, the ground realty is that it is non-functioning in most of the medical colleges. Hence by default it is assumed that doctors are good teachers and time and experience can augment teaching skills and methodologies further (5). However, in fast moving era, the entire system has changed in many parts of the world (6). In India; even today a large number of the doctors working as faculty in medical colleges are not really trained to teach. This is exactly where the Evidence Based Education System (EBES) comes to help medical educators and also it is the need of hour. EBES is the integration of professional wisdom with the best available empirical evidence in making decisions about how to deliver instructions. To put it into a simpler way; teachers opting for methods of teaching that consistently proved more effective than other teaching techniques. Professional wisdom achieved through individual experience and consensus opinion while empirical evidence is achieved through scientifically sound research. Without integration of both (professional wisdom and best evidence), medical education cannot adapt to local circumstances and even cannot operate efficiently where research evidence is absent or incomplete. If we want to understand the nitty-gritty of EBES then we have to understand different teaching methodologies. The different teaching methods are:



  1. One way Teaching Methods: (Instructor Dominated Methods)

    1. Lecture

    2. Resource person’s presentation

    3. Symposium

  2. Two Way Teaching Methods: (Learner Dominated Methods)

    1. Case Study

    2. Problem Based Learning

    3. Group Discussion

    4. Role Play

    5. Brain Storming Sessions

    6. Demonstrations

    7. Tours and Field Trips

    8. Learning by Teaching / Doing

    9. Collaboration (Group Work)

    10. Workshops

    11. Seminars

    12. Evidence Based Medicine/Dentistry

    13. Evidence Based Practice

  3. Teaching through computer (e-learning) / Lab Work Methods

Here, in Sumandeep Vidyapeeth (SV) – a deemed to be university, we are extraordinarily fortunate as Medical Educators to have a Sumandeep as our home of EBES which guides us as we begin to transform our curricula to train morrow’s doctors. We have adapted Evidence Based Medicine (EBM) and Evidence-Based Practice (EBP) as new teaching methodology for undergraduates. EBM is the reliable, explicit, and judicious use of the best current evidence in making decisions about the care of individual patients (7). In other words it is the process of systematically reviewing, appraising and using clinical research findings to aid the delivery of optimum clinical care to patients (8). While EBP is a process of care that takes the patient and his or her preferences and actions, the clinical setting including the resources available, and current and applicable scientific evidence, and knits the three together using the clinical expertise and training of the health-care providers (9).


2. Materials and Methods

We have adopted EBES on January 23, 2007 and decided to implement it in phase wise manner.


2.1. Phase I

A University Core Committee for EBES constituted in February 2007 followed by EBES Dental College Core Committee which implemented EBE in Dental College by organizing faculty lecture series. In same way in October 2007, SBKS Medical Institute and Research Centre EBES Core Committee formed which organized lecture series in December 2007 to January 2008. In April 2008, SBKS Medical Institute and Research Centre Curriculum Core Committee were formed. University Research Cell was established in the month of June 2008. In the next month, i.e., July 2008 EBE curriculum core committee for Physiotherapy College formulated. In the month of April 2009, SBKS Medical Institute and Research Centre finalized EBM curriculum.


2.2. Phase II

In May 2009, 6 faculty members deputed for advance training of Ethics in Medical Research organized by Indian Institute of Public Health-Gandhinagar. In June 2009, EBES Curriculum Committee for Allied Sciences constituted which adopted and implemented the EBE curriculum in March 2010. In first quarter of 2010, EBES lecture series for faculty was organized. In April 2010, EBES adopted and implemented by constituent institutes of SV (SBKS Medical Institute and Research Centre, Physiotherapy, Nursing, Pharmacy and Management). In October 2010, SV constituted EBES newsletter editorial board. A series of meeting were held during 18-20 October, 2010 with nursing faculty of University of Hull, UK for evidence based nursing education system.



2.3. Phase III

A State level conference on evidence based nursing education system was organized in the month of October 4th-5th, 2010. SV-EBES core committee including authors deputed for training at first international workshop in India on “How to teach EBM” during November 24-27, 2010. Second round of EBES lecture series for faculty and also two EBES workshop for nodal, departmental coordinators and faculty members were organized during December 2010 – October 2011. An international conference and workshop on EBES were organized in the month of March 2011.

Phase III also comprises of review of EBE curriculum for undergraduates, feedback from all stakeholders for acceptability, ease, advantages of EBE curriculum over traditional curriculum, and development of PG curriculum with re-assessment.

The process of development of EBE curriculum and implementation of EBE system in our university is presented as following:


1   2   3   4   5   6   7   8


Verilənlər bazası müəlliflik hüququ ilə müdafiə olunur ©atelim.com 2016
rəhbərliyinə müraciət